VANDA PHARMAC.INC.DL-,001VANDA PHARMAC.INC.DL-,001VANDA PHARMAC.INC.DL-,001

VANDA PHARMAC.INC.DL-,001

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.05EUR
Revenue estimate
‪44.95 M‬EUR
Market capitalization
‪247.81 M‬EUR
‪2.27 M‬EUR
‪174.53 M‬EUR
‪54.51 M‬
Beta (1Y)
−0.32

About Vanda Pharmaceuticals Inc.

CEO
Mihael Hristos Polymeropoulos
Headquarters
Washington
Employees (FY)
203
Founded
2002
FIGI
BBG000P03LH3
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VANDA PHARMAC.INC.DL-,001 stocks are traded under the ticker VM4.
VANDA PHARMAC.INC.DL-,001 is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
VANDA PHARMAC.INC.DL-,001 revenue for the last quarter amounts to ‪36.72 M‬ EUR despite the estimated figure of ‪42.10 M‬ EUR. In the next quarter revenue is expected to reach ‪33.52 M‬ EUR.
Yes, you can track VANDA PHARMAC.INC.DL-,001 financials in yearly and quarterly reports right on TradingView.
VM4 net income for the last quarter is ‪−2.17 M‬ EUR, while the quarter before that showed ‪129.60 K‬ EUR of net income which accounts for ‪−1.78 K‬% change. Track more VANDA PHARMAC.INC.DL-,001 financial stats to get the full picture.
No, VM4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VM4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VANDA PHARMAC.INC.DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
VM4 reached its all-time high on Dec 4, 2018 with the price of 27.32 EUR, and its all-time low was 0.36 EUR and was reached on Jan 2, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 203.00 employees. See our rating of the largest employees — is VANDA PHARMAC.INC.DL-,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VANDA PHARMAC.INC.DL-,001 EBITDA is ‪−9.91 M‬ EUR, and current EBITDA margin is −5.68%. See more stats in VANDA PHARMAC.INC.DL-,001 financial statements.